Vivos Therapeutics' VidaSleep™ oral appliance receives CMS approval, expanding treatment options for obstructive sleep apnea and snoring.

Rising temperatures may double sleep apnea cases by 2100, impacting health and economy. Study urges action to manage climate-related OSA.

Learn the risk factors for obstructive sleep apnea, from obesity to fat deposits in the neck to certain medical conditions.

Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...

Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance Treatment LITTLETON, Colo., July 01, 2025 (GLOBE ...

Find out what you need to know about how essential oils can affect sleep apnea. Discover the pros, cons, risks, and how it may benefit your health today.

Sleep Apnea: A Silent Crisis OSA is linked to severe comorbidities, including heart disease, stroke, and dementia, yet remains grossly underdiagnosed.

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

For the study, the researchers evaluated 3,102 sleep apnea patients enrolled in the Minnesota Medical Cannabis Program between August 1, 2018 and July 31, 2023. The goal of the study was to ascertain ...